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Introduction
Cancer is a non-communicable disease with about 
1.14 million new cases and 2.8 million deaths in 2012; it 
is the second cause of death after cardiovascular disease 
(Ferlay et al., 2013, Organization, 2015). Gastric cancer is 
the fifth most common cancer and the third leading cause 
of cancer related death with about 1 million new cases and 
700,000 deaths in 2012 (Ferlay et al., 2013, Pelucchi et 
al., 2015). According to a global estimates, gastric cancer 
will be one of the main causes of death in the world by 
2030; with about 2.5 million new cases and a minimum 
of 1.9 death by 2,050 (Torre et al., 2015). Gastric cancer 
is the third most common cancer after breast and skin 
cancers in Iran, According to  national report of cancer 
registry in IRAN (2008) 6,886 cases of gastric cancer 
were recorded, which represents about 3.9% of all cancers 
disease (Mousavi et al., 2009). In the Middle East, Iran 
has highest incidence rate of Gastric cancer (Mohagheghi 
et al., 2009). According to studies  in Iran, northern and 
northwestern areas of the country have the highest risk 
of gastric cancer, while central and southern areas of the 
country have moderate and low risk of stomach cancer 
respectively (Saidi et al., 2002, Sadjadi et al., 2003, Alireza 
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et al., 2005). From biological point of view, symptoms of 
gastric cancer are unknown. The disease it is very active 
and progressive and incurable in most cases (Beaglehole et 
al., 2011). Decrease  of prevalence of Helicobacter pylori 
infection and smoking and improved diet have caused a 
moderate decline in incidence rate of gastric cancer in the 
last three decades; however, the disease still remains a 
major health problem (La Vecchia and Franceschi, 2000, 
Boccia and La Vecchia, 2013). Survival analysis is one 
of the statistical methods widely used in medical studies 
in recent decades; it is a set of statistical procedures for 
data analysis in which the desired output variable is 
time until an event occurs (Kleinbaum and Klein, 2012). 
Recently, random survival forests (RSF) has been used for 
analyzing survival data. It is an ensemble tree method for 
the analysis of right censored survival data. Constructing 
ensembles from tree structures can significantly improve 
learning performance (Ishwaran and Kogalur, 2010). The 
results showed that the RSF model can identify complex 
interactions among multiple variables and outperform 
traditional CPH models (Omurlu et al., 2009, Kälin et al., 
2011, Miao et al., 2015). Factors such as age at diagnosis, 
metastasis, stage of the disease, histological grade, 
pathological stage, metastasis, and tumor size are known 
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as significant prognostic factors related to survival time 
of the patient with gastric cancer(Akhavan et al., 2013, 
Kakuta et al., 2014, Minami et al., 2015). Given the high 
prevalence of gastric cancer in the region and the lack of 
a reliable study to determine risk factors of the disease 
based on advanced statistical methods; therefore, the aim 
of our study is to identify important risk factors and their 
complex effects on Gastric cancer patients using RSF.
Materials and methods
In this historical cohort study, data from 182 
patients with gastric cancer admitted in the Referral 
Therapy Center in Hamadan, Iran from 2007 to 2013 
was analyzed. The data was extracted from the medical 
records. Survival status of patients was checked through 
telephone. Survival time was calculated from diagnosis 
to death or the end of the study (in months). Patients who 
withdrawn or lost-to-follow up for any reason during 
the study or patients who were still alive by the end of 
the study were considered as right censored. The effect 
of some demographic variables such as gender and age 
at diagnosis, as well as clinical data such as histological 
type (rivers - diffuse - complex), histopathology type 
(Adenocarcinoma - Lymphoma - Sarcoma), stage 
(I - II - III - IV), tumor location (Pyloric - Body - Fundus), 
metastatic status, number of involved lymph nodes, tumor 
size, type of treatment (Radiotherapy - chemotherapy), 
and family history of cancer on patients’ survival was 
evaluated. Staging was based on the tumor node metastasis 
system (Aronow et al., 2013).
Statistical analysis
Random survival forests
RSF is a non-parametric machine learning method for 
analyzing right censored survival data. The RSF-model 
incorporates all univariate and multivariate effects 
automatically. Another properties of RSF is that it 
can find influential covariates in highly correlated 
subsets of covariates, which is particularly useful in 
high-dimensional covariate selection problems (Ishwaran 
et al., 2008, Ishwaran and Kogalur, 2010).
The RSF algorithm
B bootstrap samples are randomly selected from the 
original dataset, while each bootstrap sample excludes 
37% of the data on average and calls out-of-bag data (OOB 
data)(Ishwaran et al., 2008, Ishwaran and Kogalur, 2010). 
In this study B=1,000.
A survival tree is grown for each bootstrap sample 
data; q=√p candidate variables are randomly selected from 
all p variables for each node in survival tree to maximize 
the survival difference between child nodes using one of 
the split criteria (log-rank, conservation of events, log-rank 
score, and random) described in (Ishwaran et al., 2008, 
Ishwaran and Kogalur, 2010). In this study, 3 candidate 
variables were randomly selected out of all 10 variables.
The tree is grown until final node’s size reaches a 
minimum number of events with unique survival times 
(Ishwaran et al., 2008, Ishwaran and Kogalur, 2010). In 
this study minimum final node size was equal to 3.
For every tree the cumulative hazard function (CHF) 
is calculated and then the ensemble CHF is obtained by 
averaging CHF. The cumulative hazard function for each 
final node in a grown tree is estimated by Nelson-Aalen’s 
estimator (Ishwaran et al., 2008, Ishwaran and Kogalur, 
2010).
Out-of-bag (OOB) error rate is calculated based on 
Harrell c-statistics for the ensemble CHF (Ishwaran et al., 
2008, Ishwaran and Kogalur, 2010).
The variable importance (VIMP) for x is the 
prediction error for the original ensemble subtracted 
from the prediction error for the new ensemble obtained 
using randomizing x assignments (Ishwaran et al., 
2008). Positive values indicate variables with predictive 
ability(important value), whereas zero or negative values 
identify non-predictive variables (not important value)
(Ishwaran et al., 2008, Ishwaran and Kogalur, 2010).
In this study the four node splitting rules was used for 
RSF approach (log-rank splitting, conservation of events 
splitting, log-rank score splitting, and random).
Harrell’s concordance index
Harrell’s concordance index (C-index) is a measure 
of survival performance. It does not depend on choosing 
a fixed time for evaluation of the model and specifically 
takes into account censoring the individuals. The 
error rate is computed as 1-C, where C is the Harrell’s 
concordance index. Error rates are between 0 and 1, 
while 0.5 corresponds to a procedure doing no better than 
random guessing and  0 is the perfect accuracy (Ishwaran 
et al., 2008).
The data were analyzed using the random Survival 
Forest package (Ishwaran et al., 2013) by R 3.1.2. In 
addition, RSF drew 1000 bootstrap samples from the 
generated data, grew a tree for each bootstrapped data 
set and split a predictor using a survival splitting rule. 
Concordance error rates were obtained from each method 
for 1,000 replications and the mean of the concordance 
error rates were recorded.
Results 
Explorative Data Analyses
The mean of age of diagnosis was 63 ±12.6 and 
mean and median survival time of the patients were 
estimated 15.1 (95%CI: 13.31, 16.99), and 12.3 (95%CI: 
11, 13.4) months respectively. The one-year, two-year, 
and three-year survival rates of the patients were 51%, 
13%, and 5% respectively (Figure1). During the study, 
146 patients died and 36 (19.8%) survived who were 
considered as of right censored observations. One hundred 
and twelve patients (61.5%) were male and 70 (38.5%) 
were female. The characteristics of the patients are listed 
in Table 1.
Random Survival Forrest Analyses
Informativeness of each predictor was taken into 
account under the log-rank splitting rule. Figure2 shows 
the error rate for the RSF log-rank model as a function of 
the number of trees and the out-of-bag importance values 
for predictors. The Right part of Figure 2 depicts the 
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model was 0.2966 (Table 2).
Figure3 illustrates the error rate for the RSF model 
as a function of the number of trees and the out-of-bag 
importance value for predictors. As shown the six 
prognostic factors (Metastatic status, Age at diagnosis, 
Tumor size, Gender, Type of treatment, and Family 
history) had an effect on survival time. Metastatic 
importance values for all 11 predictors. From the plot, we 
found that the eight prognostic factors (Metastatic status, 
Age at diagnosis, Tumor size, Number of involved lymph 
nodes, Histological type, Gender, Type of treatment, 
Tumor location) had an effect on survival time (Positive 
Value). Other predictors had negative values or no effect 
on survival time. Concordance error rate of this RSF 
Variables Number Percent Median Survival Time(Months) Log-Rank Test P-value
Gender 3.7 0.055
     Male 112 61.5 11.3
     Female 70 38.5 14.1
Family history 0.4 0.544
     Yes 17 9.4 14.1
     No 165 90.6 12.2
Age at diagnosis(yr) 8.0 0.018
     <60 73 40.1 14.1
     61-75 75 41.2 10.7
     >75 34 18.7 12.3
Tumor location 5.7 0.057
     Pyloric 100 56.8 12.4
     Body 39 22.1 10.7
     Fundus 37 21.1 14.1
Metastatic status 82.4 <0.001
     No 77 42.3 14.1
     Yes 48 26.4 7.3
     Unknown 57 31.3 16.2
Number of involved lymph nodes 15.6 <0.001
     (1-6 number) 102 75.0 12.3
     (7-15 number) 34 25.0 8.3
Histopathology type 2.5 0.279
     Adenocarcinoma 125 69.8 12.3
     Lymphoma 29 16.3 13.6
     Sarcoma 25 13.9 10.2
Tumor size 26.3 <0.001
     T1(1 cm) 21 15.2 22.0
     T2 (2 cm) 48 34.8 12.2
     T3 (3 cm) 45 31.9 11.3
     T4 (> 4cm) 25 18.1 10.3
Stage 22.4 <0.001
     I 9 5.0 22.1
     II 31 17.1 17.6
     III 36 19.9 10.7
    IV 105 58.0 11.0
Histological type 0.1 0.956
     Rivers 91 53.8 12.1
     Diffuse 56 33.1 11.3
     Complex 22 13.1 11.3
Type of treatment 5.4 0.021
     Radiotherapy 74 40.6 14.7
     Chemotherapy 108 59.4 11.2
Table 1. Characteristics of the Patients with Gastric Cancer and Univariate Analysis of Risk Factors
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status, age at diagnosis, and tumor size were assigned 
with important values by RSF log-rank splitting rule. 
Concordance error rate of th RSF model was 0.304 (Table 
2). Figure4 illustrates the error rate for the RSF model 
as a function of the number of trees and the out-of-bag 
importance values for the predictors. This figure shows 
that the four prognostic factors (Metastatic status, Age 
at diagnosis, Tumor size, and Histological type) were 
positive important values and larger than all other 
prognostic factors. Metastatic status, age at diagnosis, 
and Tumor size were given important values by RSF 
log-rank splitting rule and RSF conservation of events 
splitting rule. Concordance error rate of this RSF model 
was 0.301 (Table 2).
Figure5 pictures the error rate for the RSF model 
as a function of the number of trees and the out-of-bag 
importance values for the predictors. As indicated in the 
plot, the six prognostic factors (Metastatic status, Age 
at diagnosis, Tumor size, and Histological type, Type of 
treatment, and Family history) had an effect on survival 
time. Metastatic status, age at diagnosis, and tumor size 
had positive value by RSF log-rank splitting rule, RSF 
conservation of events splitting rule, and log-rank score 
splitting rule. Concordance error rate of this RSF model 
was 0.31 (Table 2).
Random Survival Forrest Model Performance
The performance of each RSF approach was very 
similar to the best error rate (0.297) obtained by the 
log-rank splitting rule with 1,000 trees (Table 2). The 
second, third, and fourth ranks were occupied by log-rank 
score, conservation of events, and random splitting rule 
respectively.
Figure 1. Kaplan-Meier Cumulative Survival
Figure 2. Out-of-Bag Importance Values of RSF for 
Log-Rank Splitting Rule
Method Error rate
Log-rank 0.297
RSF Log-rank scor 0.301
Conservation of events 0.304
Random 0.325
Table 2. Harrell’s Concordance Error Rates for Methods
Figure 3. Out-of-Bag Importance Values of RSF for 
Conservation of Events Splitting Rule
Figure 4. Out-of-Bag Importance Values of RSF 
for Log-Rank Score Splitting Rule
Figure 5. Out-of-Bag Importance Values of RSF for 
Random Splitting Rule
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Discussion
Each RSF approach showed a slightly different ranking 
order. The very important covariates in nearly all 4 RSF 
approaches were metastatic status, age at diagnosis, and 
tumor size. Unimportant covariates in nearly all 4 RSF 
approaches was histopathology type. The remaining 
covariates had positive importance values with somewhat 
different ranking within each RSF approach. 
Age at diagnosis time had a significant effect on 
patients’ survival time, which is consistent with the studies 
carried out in Italy, China, and north of Iran (Wang et al., 
2002, Bucchi et al., 2004, Yazdani-Charati et al., 2014). 
Metastasis was another factor that had an important value 
and significant effect on the survival time. This finding 
has been confirmed in other studies (Wang et al., 2002, 
Moghimi-Dehkordi et al., 2009, Maroufizadeh et al., 2012, 
Dixon et al., 2014). Some studies have reported that the 
disease stage highly influenced the patients’ survival time 
so that the median of survival time in stage I was more 
than median of survival time in stage IV (Zeraati et al., 
2005, Moghimi-Dehkordi et al., 2009, Dixon et al., 2014, 
Yazdani-Charati et al., 2014). This is consistent with 
our results. Consistent with (Lin et al., 2013), we found 
that tumor size was an important or significant value in 
survival time; this means that the survival time decreases 
as tumor size increases. The number of involved lymph 
nodes was another important value in this study;  by 
increasing the number of involved lymph nodes, the risk 
of death also increased ; this is inconsistent with  other 
studies including (Maroufizadeh et al., 2012). Type of the 
treatment was another important or significant factor in 
survival time. (Moghimi-Dehkordi et al., 2009) showed 
that the survival time of patients under chemotherapy 
was more than the survival time of patients who received 
radiotherapy (Moghimi-Dehkordi et al., 2009). Consistent 
with, histological type and family history were other 
factors with important effect. Moreover, histopathology 
types was not an important factor in all 4 RSF approaches 
without a significant effect on survival time. However, 
other studies have shown significant effect of this variable 
(Samadi et al., 2007, Moghimi-Dehkordi et al., 2009).
Low survival rate of gastric cancer patients is an 
indication of absence of a screening program for early 
diagnosis of the disease. Timely diagnosis in early phases 
of the disease increases survival rate and decreases 
mortality rate caused by the disease. 
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